Download PDF
Nervenheilkunde 2011; 30(08): 555-561
DOI: 10.1055/s-0038-1628394
Ulmer Heft
Schattauer GmbH

Serumcoeruloplasmin in einer randomisierten Bevölkerungsstichprobe mit 2 445 Probanden

Ceruloplasmin serum concentrations in a large randomized population sample Nervenheilkunde 2011; 30: 555–561
M. Gedack   *
1   Zentrum für Innere Medizin, I. Medizinische Klinik, Universitätsklinikum Ulm
,
M. M. Hänle
1   Zentrum für Innere Medizin, I. Medizinische Klinik, Universitätsklinikum Ulm
,
C. Schönfeldt-Lecuona
2   Klinik für Psychiatrie und Psychotherapie III, Universitätsklinikum Ulm
,
W. Kratzer
1   Zentrum für Innere Medizin, I. Medizinische Klinik, Universitätsklinikum Ulm
,
J. Kassubek
3   Klinik für Neurologie, Universitätsklinikum Ulm
,
D. Brummer
2   Klinik für Psychiatrie und Psychotherapie III, Universitätsklinikum Ulm
,
B. J. Connemann   *
2   Klinik für Psychiatrie und Psychotherapie III, Universitätsklinikum Ulm
,
EMIL Study Group › Author Affiliations
Further Information

Publication History

Eingegangen am: 01 March 2011

angenommen am: 16 March 2011

Publication Date:
23 January 2018 (online)

    Permissions and Reprints

Zusammenfassung

Die Coeruloplasmin-Serumkonzentration bezieht ihre Bedeutung für die Neuropsychiatrie aus der vermutlich ursächlichen Verknüpfung niedriger oder fehlender Werte mit Eisenstoffwechselstörungen und einer Neurodegeneration mit zerebraler Eisenakkumulation einerseits sowie aus dem Auftreten niedriger Werte bei Kupferstoffwechselstörungen mit Neurodegeneration, insbesondere M. Wilson, andererseits. Die vorliegende Untersuchung berichtet immunnephelometrische Messungen an einer randomisierten Bevölkerungsstichprobe, die im Einklang mit publizierten Werten stehen und eine Abhängigkeit der Coeruloplasmin-Serumkonzentration von Geschlecht, oraler Kontrazeption und parallel bestimmten Entzündungsparametern zeigen, darüber hinaus aber insbesondere von den Cholesterinfraktionen. Der Ausprägungsgrad dieser Abhängigkeit lässt es zweckmäßig erscheinen, diese individuellen Größen bei der Beurteilung des Serumcoeruloplasmins zu berücksichtigen.

Summary

The relevance of low ceruloplasmin serum concentrations for the differential diagnosis in neurology and psychiatry rests upon the association with neurodegenerative disorders with brain iron accumulation, on the one hand, and Wilson disease, on the other hand. The present study reports immunonephelometrical measurements of ceruloplasmin serum concentrations in a large randomized population sample. Results are in accordance with published data and show dependency on markers of inflammation, gender and history of oral contraception; in addition, a strong correlation to serum cholesterol fractions is being demonstrated. It would appear useful to account for these when evaluating ceruloplasmin serum concentrations.

Schlüsselwörter

Metallstoffwechsel - angeborene Stoffwechselstörungen - Hirnerkrankungen - heredodegenerative Störungen - neurologische und Verhaltensstörungen

Keywords

Metal metabolism - metabolism - inborn errors - brain diseases - heredodegenerative disorders - neurobehavioral manifestations

* Der Erstautor und der korrespondierende Autor trugen in gleicher Weise zu der Arbeit bei.


* Mitglieder der EMIL Study Group (alphabetisch): Adler G, Armsen A, Banzhaf H-M, Bauerdick M, Bertling U, Boehm BO, Brandner BO, Brockmann SO, Deckert M, Dingler C, Eggink S, Fuchs M, Gaus W, Goussis H, Gruenert A, Haenle MM, Hampl W, Haug C, Hay B, Huetter M-L, Imhof A, Kern P, Kimmig P, Kirch A, Klass D, Koenig W, Kratzer W, Kron M, Manfras B, Meitinger K, Mertens T, Oehme R, Pfaff G, Piechotowski I, Reuter S, Romig T, von Schmiesing AFA, Steinbach G, Tourbier M, Voegtle A, Walcher T, Wolff S.


 

  • Literatur

  • 1 Abood LG, Gibbs FA, Gibbs E. Comparative study of blood ceruloplasmin in schizophrenia and other disorders. AMA Arch Neurol Psychiatr 1957; 77: 643-5.
    Google Scholar
  • 2 Akerfeldt S. Oxidation of N, N-dimethyl-p-phenylenediamine by serum from patients with mental disease. Science 1957; 125 (3238): 117-9.
    CrossrefPubMedGoogle Scholar
  • 3 Bock E, Weeke B, Rafaelsen OJ. Serum proteins in acutely psychotic patients. J Psychiatr Res 1971; 09: 1-9.
    CrossrefPubMedGoogle Scholar
  • 4 Boehm BO. et al. Prevalence of the metabolic syndrome in southwest Germany. Scand J ClinLab Invest Suppl 2005; 240: 122-8.
    Google Scholar
  • 5 Connemann BJ. et al. Die Bedeutung des Serum-Coeruloplasmins für die Differentialdiagnose neuropsychiatrischer Störungen. Fortschr Neurol Psychiatr 2010; 78: 582-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Cox DW. Factors influencing serum ceruloplasmin levels in normal individuals. J Lab Clin Med 1966; 68: 893-904.
    PubMedGoogle Scholar
  • 7 Ganrot PO. Variation of the concentrations of some plasma proteins in normal adults, in pregnant women and in newborns. Scand J Clin Lab Invest Suppl 1972; 124: 83-8.
    Google Scholar
  • 8 Gregg XT, Reddy V, Prchal JT. Copper deficiency masquerading as myelodysplastic syndrome. Blood 2002; 100: 1493-5.
    CrossrefPubMedGoogle Scholar
  • 9 Harris ZL, Durley AP, Man TK, Gitlin JD. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci USA 1999; 96: 10812-7.
    CrossrefPubMedGoogle Scholar
  • 10 Harris ZL. Not all absent serum ceruloplasmin is Wilson disease: a review of aceruloplasminemia. J Investig Med 2002; 50: 236-8.
    Google Scholar
  • 11 Heilmeyer L, Keiderling W, Struve C. Kupfer und Eisen als körpereigne Wirkstoffe und ihre Bedeutung beim Krankheitsgeschehen. Jena: Fischer; 1941
    Google Scholar
  • 12 Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr 2002; 22: 439-58.
    CrossrefPubMedGoogle Scholar
  • 13 Holmberg CG, Laurell CB. Investigations in serum copper. II. Isolation of the copper-containing protein and a description of some of its properties. Acta Chem Scand 1948; 02: 550-6.
    CrossrefGoogle Scholar
  • 14 Ichihara K, Kawai T. Determination of reference intervals for 13 plasma proteins based on IFCC international reference preparation [CRM470] and NCCLS proposed guideline [C28-P,1992]: trial to select reference individuals by results of screening tests and application of maximal likelihood method. J Clin Lab Anal 1996; 10: 110-7.
    CrossrefPubMedGoogle Scholar
  • 15 Kaneko K. et al. Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia. J Neuropathol Exp Neurol 2002; 61: 1069-77.
    CrossrefPubMedGoogle Scholar
  • 16 Kono S, Miyajima H. Molecular and pathological basis of aceruloplasminemia. Biol Res 2006; 39: 15-23.
    Google Scholar
  • 17 Koschinsky ML. et al. Complete cDNA sequence of human preceruloplasmin. Proc Natl Acad Sci USA 1986; 83: 5086-90.
    CrossrefPubMedGoogle Scholar
  • 18 Kumar N. et al. Copper deficiency myelopathy. Arch Neurol 2004; 61: 762-6.
    CrossrefPubMedGoogle Scholar
  • 19 Lehmann HP, Schosinsky KH, Beeler MF. Standardization of serum ceruloplasmin concentrations in international enzyme units with o-dianisidine dihydrochloride as substrate. Clin Chem 1974; 20: 1564-7.
    PubMedGoogle Scholar
  • 20 Markowitz H. et al. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration, and the nephritic syndrome. J Clin Invest 1955; 34: 1498-508.
    CrossrefPubMedGoogle Scholar
  • 21 Martens S, Valbo S, Melander B. Studies on the role of ceruloplasmin in schizophrenia. Acta psych neurol scand 1959; 34 Suppl 136: 349-60.
    Google Scholar
  • 22 Meyer LA. et al. Copper transport and metabolism are normal in aceruloplasminemic mice. J Biol Chem 2001; 276: 36857-61.
    CrossrefPubMedGoogle Scholar
  • 23 Miyajima H. et al. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 1987; 37: 761-7.
    CrossrefPubMedGoogle Scholar
  • 24 Miyajima H. Aceruloplasminemia, an iron metabolic disorder. Neuropathology 2003; 23: 345-50.
    CrossrefPubMedGoogle Scholar
  • 25 Morell AG. et al. Measurement of concentration of ceruloplasmin in serum by determination of its oxidase activity. In: Sunderman FW, Sunderman Jr FW. (Hrsg.). Laboratory diagnosis of liver diseases. St Louis: Greene; 1968
    Google Scholar
  • 26 Olantunbosun D. et al. Serum copper in schizophrenia in Nigerians. Br J Psychiatry 1975; 127: 119-21.
    CrossrefPubMedGoogle Scholar
  • 27 Osaki S, Johnson DA, Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem 1966; 241: 2746-51.
    PubMedGoogle Scholar
  • 28 Rahman B, Rahman MA, Hassan Z. Variation of copper and ceruloplasmin levels with liver function tests in schizophrenic patients. Biomedicine 1978; 29: 238-41.
    PubMedGoogle Scholar
  • 29 Scheinberg I. Ceruloplasmin test for Wilson’s disease. Pediatrics 1963; 31: 160-1.
    Google Scholar
  • 30 Scheinberg IH, Gitlin D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration [Wilson’s disease]. Science 1952; 116 (3018): 484-5.
    CrossrefPubMedGoogle Scholar
  • 31 Scheinberg IH. et al. Concentration of ceruloplasmin in plasma of schizophrenic patients. Science 1957; 126 (3279): 925-6.
    CrossrefPubMedGoogle Scholar
  • 32 Schosinsky KH, Lehmann HP, Beeler MF. Automated determination of serum ceruloplasmin activity with o-dianisidine dihydrochloride as substrate. Clin Chem 1975; 21: 757-9.
    PubMedGoogle Scholar
  • 33 Secchi GC, Petrella A, Lomanto B, Gervasini N. Ceruloplasmin activity in liver diseases. Quantitative determination and electrophoretic characterization. Enzym biol clin 1967; 08: 33-41.
    Google Scholar
  • 34 Störiko K. Normal values for 23 different human plasma proteins determined by single radial immunodiffusion. Blut 1968; 16: 200-8.
    CrossrefPubMedGoogle Scholar
  • 35 Sunderman FW, Nomoto S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chemistry 1970; 16: 903-10.
    PubMedGoogle Scholar
  • 36 Weiss WA. Normalwerte spezifischer Serumproteine im Kindes -und Erwachsenenalter. Klin Wochenschr 1965; 43: 273-7.
    CrossrefPubMedGoogle Scholar
  • 37 Wilson SAK. Progressive lenticular degeneration: a familial nervous system disease associated with cirrhosis of the liver. Brain 1912; 34: 295-509.
    CrossrefGoogle Scholar
  • 38 Yunice AA, Lindeman RD, Czerwinski AW, Clark M. Influence of age and sex on serum copper and ceruloplasmin levels. J Gerontol 1974; 29: 277-81.
    CrossrefPubMedGoogle Scholar